Send Inquiry

Request To Call Back

Celdach 100 mg Injection

Name: Celdach 100 mg Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 1915.0 INR
Availability: InStock

Price 1915.0 INR/ Piece

Get a Price/Quote

MOQ : 105 Pieces

Celdach 100 mg Injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
Celdach

Dosage Form
Lyophilized powder for solution

Salt Composition
Dacarbazine

Indication
Treatment of malignant melanoma and Hodgkins lymphoma

Packaging Type
Vial

Life Span
24 months

Origin of Medicine
INDIA

Drug Type
Prescription only

Ingredients
Dacarbazine 100 mg

Physical Form
Liquid

Function

Recommended For
DOCTOR

Dosage
As directed by physician

Dosage Guidelines
Administer intravenously under medical supervision

Suitable For
Allopathy

Quantity
105 Pieces

Storage Instructions
Store below 25C, protect from light

Manufactured By
Celon Laboratories Ltd.

Route of Administration
Intravenous

Shelf Life After Reconstitution
Use immediately

Appearance
White to pale yellow lyophilized powder

Prescription Required
Yes

Marketed By
Celon Laboratories Ltd.

Regulatory Approval
WHO-GMP Certified

Common Side Effects
Nausea, vomiting, myelosuppression, flu-like symptoms

Reconstitution Solvent
Sterile Water for Injection

ATC Code
L01AX04

Contraindications
Hypersensitivity to dacarbazine or any component

Celdach 100 mg Injection Trade Information

Minimum Order Quantity
105 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
1 Week

About Celdach 100 mg Injection

Celdach 100 mg Injection is an effective treatment option for individuals diagnosed with colon and rectal cancer, functioning by targeting and inhibiting the proliferation of malignant cells. This powerful medication disrupts the growth signals within cancerous tissues, thereby helping to slow down or halt tumor progression. It is crucial for patients to be aware of potential side effects, including nausea, fatigue, and changes in blood cell counts, which should be monitored closely by healthcare professionals. Patients should also inform their doctors of any existing health conditions or medications to avoid adverse interactions. As with any cancer treatment, Celdach should be administered under the supervision of a qualified healthcare provider to ensure safety and efficacy. Regular follow-up appointments are essential for tracking progress and adjusting treatment as necessary. By combining Celdach with a comprehensive treatment plan, including surgery and radiation when appropriate, patients can enhance their overall chances of recovery. Always discuss your treatment options thoroughly with your oncologist to make informed decisions tailored to your health needs.

Essential Chemotherapy Agent

Celdach 100 mg Injection plays a crucial role in modern chemotherapy protocols, primarily targeting malignant melanoma and Hodgkin's lymphoma. Its active ingredient, dacarbazine, interrupts cancer cell growth, offering a vital therapeutic option under medical supervision. The drug is recommended for use in hospital settings, where healthcare providers can closely monitor patient response.

Usage and Administration Guidelines

Designed for intravenous administration only, Celdach 100 mg Injection must be prepared by reconstituting the lyophilized powder with sterile water. It should always be administered immediately after reconstitution to ensure stability. Patients must rely on medical professionals for both preparation and administration, strictly following the physician's dosage directives.

FAQ's of Celdach 100 mg Injection:

Q: How should Celdach 100 mg Injection be administered?

A: Celdach 100 mg Injection is for intravenous use and must be reconstituted with sterile water before administration. It should only be given by a healthcare professional in a clinical setting, following the physician's prescribed dosage.

Q: What are the indications for using Celdach 100 mg Injection?

A: Celdach 100 mg Injection is primarily indicated for the treatment of malignant melanoma and Hodgkin's lymphoma. It is a chemotherapy agent that disrupts cancer cell proliferation.

Q: When should the reconstituted solution be used?

A: The reconstituted Celdach solution should be used immediately after preparation to maintain its effectiveness and prevent contamination.

Q: Where should Celdach 100 mg Injection be stored?

A: It should be stored below 25C and protected from light. The drug should be kept in its original packaging until use, in a controlled medical facility or pharmacy.

Q: What should I do in case of hypersensitivity to dacarbazine or other components?

A: Celdach 100 mg Injection is contraindicated in patients with known hypersensitivity to dacarbazine or any of its constituents. Inform your healthcare provider of all allergies before beginning treatment.

Q: What are the common side effects of Celdach 100 mg Injection?

A: Frequent side effects include nausea, vomiting, flu-like symptoms, and myelosuppression. Medical supervision is essential to manage and monitor these effects during therapy.

Q: What is the main benefit of Celdach 100 mg Injection therapy?

A: The primary benefit of Celdach 100 mg Injection is its effectiveness in treating specific cancers such as malignant melanoma and Hodgkin's lymphoma, when administered appropriately under medical supervision.

Tell us about your requirement